October 1, 2018 / 12:55 PM / 2 months ago

Fresenius shares jump on report of win in Akorn ruling

LONDON (Reuters) - Shares in German healthcare group Fresenius (FREG.DE) surged up 9.3 percent on Monday after a Bloomberg report that the firm won a ruling to pull out of a $4.3 billion deal to buy U.S. generic pharmaceuticals company Akorn (AKRX.O).

Akorn shares were down around 47 percent in pre-market trading in the U.S., before being halted.

Fresenius was not immediately available to comment on the report.

Reporting by Helen Reid, Editing by Julien Ponthus

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below